TRAF3 and myeloid leukemia: In sharp contrast, PEP005 stimulated the proliferation of primary TRAF3-/- B lymphoma cells at the dose range (10 to 100 nM) that has been previously shown to display anti-tumor activity on myeloid leukemia cells [23,24] (Additional file 1: Figure S1A and 1B).